PRESENTATION

Q2 FY2021 — Presentation

Q2 FY2021PDF · 28 pages1.3 MB
© 2021 Micron Technology, Inc. All rights reserved. Information, products, and/or specifications are subject to change without notice. All information is provided on an “AS IS” basis without warranties of any kind. Statements
regarding products, including statements regarding product features, availability, functionality, or compatibility, are provided for informational purposes only and do not modify the warranty, if any, applicable to any product.
Drawings may not be to scale. Micron, the Micron orbit logo, the M orbit logo, Intelligence Accelerated™, and other Micron trademarks are the property of Micron Technology, Inc. All other trademarks are the property of their
respective owners.
Financial Results
FQ2 2021

-- 1 of 28 --

Safe Harbor Statement
March 31, 2021
2
During the course of this meeting, we may make projections or other forward-looking statements
regarding future events or the future financial performance of the Company and the industry. We
wish to caution you that such statements are predictions and that actual events or results may differ
materially. We refer you to the documents the Company files from time to time with the Securities
and Exchange Commission, specifically the Company’s most recent Form 10-K and Form 10-Q.
These documents contain and identify important factors that could cause the actual results for the
Company to differ materially from those contained in our projections or forward-looking statements.
These certain factors can be found at http://www.micron.com/certainfactors. Although we believe that
the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee
future results, levels of activity, performance, or achievements. We are under no duty to update any
of the forward-looking statements after the date of the presentation to conform these statements to
actual results.

-- 2 of 28 --

March 31, 2021
3
Sanjay Mehrotra
President and CEO

-- 3 of 28 --

March 31, 2021
4
Highlights
▪ Delivered strong FQ2 results above our original projections driven
by solid execution and higher-than-expected demand across
multiple end markets
▪ DRAM market is in severe shortage, and NAND market is showing
signs of stabilization in the near term
▪ Set revenue records for mobile MCPs and automotive
▪ Reached normal levels of inventory ahead of schedule
▪ Began volume production of our 1-alpha DRAM node, solidifying our
technology leadership in both DRAM and NAND

-- 4 of 28 --

Operations
March 31, 2021
5
▪ We are confident our COVID-19 safety protocols will allow us to continue at full
production levels
▪ Have been able to mitigate the impact of broad electronics-industry shortages to
our production output through our proactive supply chain and inventory
management strategies
▪ Investments made over the last several years in facilities infrastructure allowed
us to minimize lost output caused by the power outage and earthquake at our
Taiwan operations in December
▪ Due to drought in central Taiwan, there has been a reduction in the water supply
at one of DRAM fab sites; we have secured alternative sources of water to
mitigate the water shortage; at this time, we do not see an impact
to DRAM production output

-- 5 of 28 --

Solid progress toward our goals:
▪ Deliver industry-leading technology and
improve our cost structure
▪ Bring differentiated products to market and
improve our product mix
▪ Grow our share of industry profits while
maintaining stable bit share
Micron was one of the top 20 U.S. patent
registrants in 2020. This achievement
attests to the brilliant innovation of our
teams and is proof of the tenacious focus
we have placed on technology and product
leadership over the past several years.
DRAM NAND
▪ 1-alpha DRAM node in volume
production and ramping on plan
▪ Expect it to be our workhorse for FY22,
fueling our bit growth and contributing
to our long-term cost reduction goals
▪ On track to support customers as they
begin to introduce DDR5 in 2HFY21
▪ 176-layer NAND node in volume
production and ramping on plan
▪ Expect it to be our workhorse for
FY22, fueling our bit growth and
contributing to our long-term
cost reduction goals
▪ Driving an increased mix of QLC
NAND. Achieved a record-high
QLC bit mix in FQ2
6
March 31, 2021
Strong Technology
and Roadmap
Execution

-- 6 of 28 --

End Market Highlights
March 31, 2021
7
Mobile & Intelligent Edge
▪ Mobile: Revenue grew 21% Q/Q, driven
by strong execution coupled with better-than-
seasonal demand
▪ Achieved record MCP revenue, and nearly
tripled our LP5 revenue Q/Q
▪ Have also begun sampling the industry’s first
1-alpha LPDRAM and 176-layer NAND with
mobile customers
▪ 5G momentum is continuing
▪ Auto: Second consecutive record-
revenue quarter
▪ Completed qualification of our auto-grade LP5
and began sampling the industry’s first
automotive LP5 that is hardware-evaluated to
meet the most stringent Automotive Safety
Integrity Level, ASIL D
Data Center
▪ Memory and storage becoming an
increasing portion of server BOM cost
▪ Enterprise DRAM bit shipments grew
sharply Q/Q but were still down Y/Y;
demand is starting to improve as IT
budgets increase in anticipation of
economic recovery
▪ Cloud DRAM bit shipments also grew
Q/Q; anticipate robust demand from U.S.
hyperscale customers, especially
2HCY21
▪ Continuing to expand our data center
NVMe SSD portfolio with internally
developed controllers and have new
product introductions planned in the
coming quarters
PC & Graphics
▪ PC: Delivered record PC DRAM
shipments despite pockets of non-
memory component shortages
experienced in the PC OEM supply chain
▪ Began sampling 1-alpha-based
DDR4 products
▪ In client SSDs, on track to begin customer
qualification of our next-gen client SSDs
using 176-layer NAND in 2HFY21
▪ Graphics: FQ2 revenue declined Q/Q
from an exceptional FQ1 but grew
significantly Y/Y

-- 7 of 28 --

Outlook
March 31, 2021
8
Industry
▪ CY-21 DRAM industry bit demand growth of approximately 20%, with DRAM industry supply to be below
demand; DRAM market is currently facing a severe undersupply, causing DRAM prices to increase rapidly
▪ CY-21 NAND industry bit demand growth in the low-to-mid 30% range, with NAND industry supply
exceeding demand; more CapEx cuts are needed to allow for healthy NAND industry profitability
▪ Long-term DRAM industry bit demand growth CAGR of mid-to-high teens
▪ Long-term NAND bit demand growth CAGR of approximately 30%
Micron ▪ CY-21 DRAM & NAND Micron bit supply growth expected to be below industry demand growth
▪ Long-term DRAM & NAND Micron bit supply growth CAGR in line with industry demand growth CAGR
▪ Across DRAM & NAND we target long-term cost reductions in line with industry

-- 8 of 28 --

March 31, 2021
9
Dave Zinsner
Chief Financial Officer

-- 9 of 28 --

FQ2-21 Revenue
$6.2B
Revenue up 8% Q/Q and up 30% Y/Y
March 31, 2021
10

-- 10 of 28 --

March 31, 2021
11
Performance
by Technology
DRAM ▪ 71% of total revenue in FQ2-21
▪ Revenue up 10% Q/Q and up 44% Y/Y
▪ Bit shipments up high-single-digit percent range Q/Q
▪ ASPs up slightly Q/Q
NAND ▪ 26% of total revenue in FQ2-21
▪ Revenue up 5% Q/Q and up 9% Y/Y
▪ Bit shipments up high-single-digit percent range Q/Q
▪ ASPs down low-single-digit percent range Q/Q

-- 11 of 28 --

March 31, 2021
12
Revenue by Business Unit
Amounts in millions
FQ2-21 FQ1-21 Q/Q % Change FQ2-20 Y/Y % Change
Compute and Networking (CNBU) $2,636 $2,546 4% $1,967 34%
Mobile (MBU) $1,811 $1,501 21% $1,258 44%
Storage (SBU) $850 $911 (7)% $870 (2)%
Embedded (EBU) $935 $809 16% $696 34%

-- 12 of 28 --

March 31, 2021
FQ2-21
Non-GAAP Operating Results
Revenue: $6.2 billion
Gross Margin: 32.9%
Operating Expenses: $797 million
Operating Income: $1.3 billion
Net Income: $1.1 billion
Diluted EPS: $0.98
Adjusted EBITDA: $2.8 billion
Cash from Operations (GAAP): $3.1 billion
13

-- 13 of 28 --

1Capex net of amounts funded by partners and proceeds from sales of property, plant, and equipment
2Cash, short-term and long-term marketable investments, restricted cash, and undrawn revolver capacity
3Cash, short-term and long-term marketable investments, and restricted cash
1
2
3
Cash
Return
Net
CapEx1
Liquidity2Cash3-
Debt
Capital Allocation
March 31, 2021
14
$2.8B total share repurchases in
FY19 and FY20
$1.9B of net cash at end
of FQ2-21
FY-21 CapEx of ~$9B
$11.1B in liquidity at end
of FQ2-21

-- 14 of 28 --

March 31, 2021
15
FQ3-21 Guidance
Revenue $7.1 billion ± $200 million
Gross margin 41.5% ± 1%
Operating expenses $875 million ± $25 million
Interest (income) expense, net $25 million
Diluted EPS* $1.62 ± $0.07
Non-GAAP
*Based on ~1.16 billion diluted shares

-- 15 of 28 --

Other Key Data
March 31, 2021
17

-- 16 of 28 --

March 31, 2021
18
Financial Summary
Non-GAAP
See non-GAAP reconciliations
Amounts in millions, except per share FQ2-21 % of
Revenue FQ1-21 % of
Revenue FQ2-20 % of
Revenue
Revenue $6,236 100% $5,773 100% $4,797 100%
Gross margin 2,054 33% 1,784 31% 1,398 29%
Operating income 1,257 20% 973 17% 542 11%
Income tax (provision) benefit (125) (71) (17)
Net income attributable to Micron 1,128 18% 897 16% 517 11%
Diluted earnings per share 0.98 0.78 0.45
Cash provided by operating activities (GAAP) 3,057 1,967 2,001
Cash, marketable investments, and restricted
cash (GAAP) 8,567 8,363 8,120

-- 17 of 28 --

March 31, 2021
19
Non-GAAP Financial Data and Guidance
% of Revenue FQ2-21
DRAM 71%
NAND 26%
See non-GAAP reconciliations
% Sales Volume Change FQ2-21 Q/Q
DRAM Increased high-single-digit
percent range
NAND Increased high-single-digit
percent range
% ASP Change FQ2-21 Q/Q
DRAM Increased slightly
NAND Decreased low-single-digit
percent range
FQ2-21 Non-GAAP
(amounts in millions,
except per share)
FQ3-21
Non-GAAP Guidance
Revenue $ 6,236 $7.1 billion ± $200 million
Gross margin 32.9% 41.5% ± 1%
Operating expenses $ 797 $875 million ± $25 million
Interest (income) expense, net $ 24 $25 million
Diluted earnings per share $ 0.98 $1.62 ± $0.07
FQ2-21 Non-GAAP
(amounts in millions)
FQ3-21
Non-GAAP Estimates
Diluted shares 1,154 ~1.16 billion
Income tax (provision) benefit $ (125) High-single-digit rate
Cash from operations (GAAP) $ 3,057 —
Depreciation and amortization $ 1,542 —
Investments in capex, net
(capital cash flow) $ 2,883 FY-21: ~$9 billion

-- 18 of 28 --

March 31, 2021
20
Revenue by Technology
Amounts in millions FQ2-21 % of
Revenue FQ1-21 % of
Revenue FQ2-20 % of
Revenue
DRAM $4,444 71% $4,056 70% $3,083 64%
NAND 1,650 26% 1,574 27% 1,514 32%
Other 142 2% 143 2% 200 4%
Total $6,236 100% $5,773 100% $4,797 100%
Percentages of total revenue may not total 100% due to rounding.

-- 19 of 28 --

Non-GAAP Reconciliations
21
March 31, 2021

-- 20 of 28 --

March 31, 2021
22
Consolidated Results
Non-GAAP Reconciliations
Amounts in millions FQ2-21 FQ1-21 FQ2-20
GAAP gross margin $ 1,649 $ 1,736 $ 1,355
Inventory accounting policy change to FIFO 133 — —
Change in inventory cost absorption 160 — —
3D XPoint inventory write-down 49 — —
Stock-based compensation 57 41 37
Other 6 7 6
Non-GAAP gross margin $ 2,054 $ 1,784 $ 1,398
GAAP operating expenses $ 986 $ 870 $ 915
Stock-based compensation (55) (51) (48)
Patent license charges (128) — —
Restructure and asset impairments (5) (8) (10)
Other (1) — (1)
Non-GAAP operating expenses $ 797 $ 811 $ 856

-- 21 of 28 --

March 31, 2021
23
Consolidated Results
Non-GAAP Reconciliations
Amounts in millions FQ2-21 FQ1-21 FQ2-20
GAAP operating income $ 663 $ 866 $ 440
Inventory accounting policy change to FIFO 133 — —
Change in inventory cost absorption 160 — —
3D XPoint inventory write-down 49 — —
Stock-based compensation 112 92 85
Patent license charges 128 — —
Restructure and asset impairments 5 8 10
Other 7 7 7
Non-GAAP operating income $ 1,257 $ 973 $ 542

-- 22 of 28 --

March 31, 2021
24
Consolidated Results
Non-GAAP Reconciliations
Amounts in millions FQ2-21 FQ1-21 FQ2-20
GAAP cost of goods sold $ 4,587 $ 4,037 $ 3,442
Inventory accounting policy change to FIFO (133) — —
Change in inventory cost absorption (160) — —
3D XPoint inventory write-down (49) — —
Stock-based compensation (57) (41) (37)
Other (6) (7) (6)
Non-GAAP cost of goods sold $ 4,182 $ 3,989 $ 3,399
GAAP research and development $ 641 $ 647 $ 681
Stock-based compensation (29) (24) (22)
Other (1) — (1)
Non-GAAP research and development $ 611 $ 623 $ 658
GAAP selling, general and administrative $ 214 $ 214 $ 223
Stock-based compensation (26) (27) (26)
Non-GAAP selling, general and administrative $ 188 $ 187 $ 197

-- 23 of 28 --

March 31, 2021
25
Consolidated Results
Non-GAAP Reconciliations
Amounts in millions FQ2-21 FQ1-21 FQ2-20
GAAP net income attributable to Micron $ 603 $ 803 $ 405
Inventory accounting policy change to FIFO 133 — —
Change in inventory cost absorption 160 — —
3D XPoint inventory write-down 49 — —
Stock-based compensation 112 92 85
Patent license charges 128 — —
Restructure and asset impairments 5 8 10
Amortization of debt discount and other costs 8 7 6
Other 7 7 7
Estimated tax effects of above and non-cash changes in net deferred income taxes (77) (20) 4
Non-GAAP net income attributable to Micron $ 1,128 $ 897 $ 517
GAAP interest (income) expense, net $ 32 $ 38 $ 12
Amortization of debt discount and other costs (8) (7) (6)
Non-GAAP interest (income) expense, net $ 24 $ 31 $ 6
GAAP income tax (provision) benefit $ (48) $ (51) $ (21)
Estimated tax effects of non-GAAP adjustments and non-cash changes in net
deferred income taxes (77) (20) 4
Non-GAAP income tax (provision) benefit $ (125) $ (71) $ (17)

-- 24 of 28 --

March 31, 2021
26
Consolidated Results
Non-GAAP Reconciliations
Amounts in millions FQ2-21 FQ1-21 FQ2-20
GAAP shares used in diluted EPS calculations 1,144 1,135 1,133
Adjustment for stock-based compensation and capped calls 10 11 11
Non-GAAP shares used in diluted EPS calculations 1,154 1,146 1,144
GAAP diluted earnings per share $ 0.53 $ 0.71 $ 0.36
Effects of non-GAAP adjustments 0.45 0.07 0.09
Non-GAAP diluted earnings per share $ 0.98 $ 0.78 $ 0.45
GAAP net income $ 603 $ 803 $ 407
Interest (income) expense, net 32 38 12
Provision (benefit) for income taxes 48 51 21
Depreciation and amortization of property, plant, and equipment and intangibles 1,549 1,487 1,365
Non-GAAP adjustments
Inventory accounting policy change to FIFO 133 — —
Change in inventory cost absorption 160 — —
3D XPoint inventory write-down 49 — —
Stock-based compensation 112 92 85
Patent license charges 128 — —
Restructure and asset impairments 5 8 10
Adjusted EBITDA $ 2,819 $ 2,479 $ 1,900

-- 25 of 28 --

March 31, 2021
27
Consolidated Results
Non-GAAP Reconciliations
*Expenditures for property, plant and equipment, net include proceeds from sales of property, plant, and equipment of $18 million for FQ2-21, $12 million for FQ1-21, and $43 million for FQ2-20.
Amounts in millions FQ2-21 FQ1-21 FQ2-20
Net cash provided by operating activities $ 3,057 $ 1,967 $ 2,001
Investments in capital expenditures, net
Expenditures for property, plant, and equipment, net* (3,000) (2,726) (2,013)
Payments on equipment purchase contracts (26) (97) (18)
Amounts funded by partners 143 40 93
Adjusted free cash flow $ 174 $ (816) $ 63
Amounts in millions FQ2-21 FQ1-21
Cash and short-term investments $ 7,184 $ 7,032
Current and noncurrent restricted cash 67 67
Long-term marketable investments 1,316 1,264
Current and long-term debt (6,621) (6,629)
Net cash $ 1,946 $ 1,734

-- 26 of 28 --

March 31, 2021
28
FQ3-21 Guidance
Non-GAAP Reconciliations
*GAAP EPS based on ~1.15 billion diluted shares and non-GAAP EPS based on ~1.16 billion diluted shares.
The above guidance does not incorporate the impact of any potential business combinations, divestitures, restructuring activities, balance sheet valuation adjustments, strategic investments, financing transactions, and other
significant transactions. The timing and impact of such items are dependent on future events that may be uncertain or outside of our control.
GAAP Adjustments Non-GAAP
Revenue $7.1 billion ± $200 million — $7.1 billion ± $200 million
Gross margin 40.5% ± 1% 1% A 41.5% ± 1%
Operating expenses $930 million ± $25 million $55 million B $875 million ± $25 million
Interest (income) expense, net $27 million $2 million C $25 million
Diluted EPS* $1.52 ± $0.07 $0.10 A,B,C,D $1.62 ± $0.07
Adjustments (amounts in millions)
A Stock-based compensation – cost of goods sold $ 46
A Other – cost of goods sold 7
B Stock-based compensation – research and development 29
B Stock-based compensation – sales, general, and administrative 26
C Amortization of debt discount and other costs 2
D Tax effects of the above items and non-cash changes in net deferred income taxes 2
$ 112

-- 27 of 28 --

March 31, 2021
28

-- 28 of 28 --